RSS feed (help and list of feeds)
Notification
Search for previous notification documents
- Termination of Fensic (fentanyl transdermal patch) agreement (1 page, 94 KB) 24 Nov 2009
- Approval of a proposal regarding Sigma’s brands of furosemide tablets, ethambutol tablets and atropine eye drops (2 pages, 146 KB) 13 Nov 2009
- Notification of widening access of tenofovir (4 pages, 79 KB) 10 Nov 2009
- Notification of decline of funding proposal for Lantus (insulin glargine), Apidra (insulin glulisine) and Betadine (povidone iodine) (2 pages, 141 KB) 09 Nov 2009
- Funding of a new brand of grans for oral liquid amoxycillin 125mg per 5 ml (2 pages, 27 KB) 30 Oct 2009
- Notification of proposal relating to Baxter Healthcare’s IV and irrigation fluids (1 page, 96 KB) 30 Oct 2009
- October Tender Results (2 pages, 108 KB) 30 Oct 2009
- Notification of letrozole Tender decision (1 page, 153 KB) 13 Oct 2009
- Additional Tender notification (1 page, 108 KB) 06 Oct 2009
- Approval of funding for Dr Reddy’s Risperidone (1 page, 34 KB) 30 Sep 2009
- Information relating to the third pharmacy payment (3 pages, 122 KB) 30 Sep 2009
- Notification of approval of funding for mirtazapine (2 pages, 38 KB) 30 Sep 2009
- September Tender Results (4 pages, 123 KB) 30 Sep 2009
- Notification - lansoprazole (Solox) supply agreement approved (1 page, 22 KB) 28 Sep 2009
- Approval of Multiple Diabetes Management Products (3 pages, 195 KB) 09 Sep 2009
- Notification of approved proposal relating to alendronate, aprepitant, raltegravir, levodopa with carbidopa, timolol and dorzolamide with timolol (5 pages, 87 KB) 03 Sep 2009
Page updated on 24 Nov 2009
Linked documents
Termination of Fensic (fentanyl transdermal patch) agreement (1 page, 94 KB)
24 November 2009 Termination of Fensic (fentanyl transdermal patch) agreement PHARMAC wishes to advise that the agreement it had entered into with Mylan New Zealand Ltd (formerly Pacific Pharmaceuticals) for the supply of Fensic (fentanyl transdermal patches) has been terminated…
Approval of a proposal regarding Sigma’s brands of furosemide tablets, ethambutol tablets and atropine eye drops (2 pages, 146 KB)
13 November 2009 Approval of a proposal regarding Sigma’s brands of furosemide tablets (Urex Forte), ethambutol tablets (Myambutol) and atropine eye drops (Atropt) PHARMAC is pleased to announce the listing of ethambutol 100 mg and furosemide 500 mg tablets in…
Notification of widening access of tenofovir (4 pages, 79 KB)
10 November 2009 Widening of access to tenofovir for the treatment of patients with treatment-resistant hepatitis B virus infection PHARMAC is pleased to announce a decision to widen access to tenofovir disproxil fumarate (‘tenofovir’) for the treatment of patients with…
Notification of decline of funding proposal for Lantus (insulin glargine), Apidra (insulin glulisine) and Betadine (povidone iodine) (2 pages, 141 KB)
9 November 2009 Notification of decline of funding proposal for Lantus (insulin glargine), Apidra (insulin glulisine) and Betadine (povidone iodine) PHARMAC wishes to inform that the PHARMAC Board has decided to decline a proposal relating to the widening of access…
Funding of a new brand of grans for oral liquid amoxycillin 125mg per 5 ml (2 pages, 27 KB)
30 October 2009 Funding of a new brand of grans for oral liquid amoxycillin 125mg per 5 ml PHARMAC is pleased to announce that the approval of an agreement with Sandoz Pty Limited. This was the subject of a consultation…
Notification of proposal relating to Baxter Healthcare’s IV and irrigation fluids (1 page, 96 KB)
30 October 2009 Proposal relating to Baxter Healthcare’s IV and irrigation fluids PHARMAC has approved a proposal to amend the listing of a number of intravenous (IV) fluids supplied by Baxter Healthcare, and list a number of new irrigation fluids,…
October Tender Results (2 pages, 108 KB)
30 October 2009 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 21…
Notification of letrozole Tender decision (1 page, 153 KB)
13 October 2009 Notification of letrozole Tender decision PHARMAC is pleased to announce its decision to award the Tender for letrozole 2.5 mg tablet to Douglas Pharmaceuticals Ltd, as a result of the Invitation to Tender dated 23 December 2008.…
Additional Tender notification (1 page, 108 KB)
2 October 2009 TENDER RESULTS – OMISSION FROM THE TENDER NOTIFICATION DATED 30 SEPTEMBER 2009 Please note that the tender decision for etidronate disodium 200 mg tablet was omitted from the Tender Notification sent on 30 September 2009, this decision…
Approval of funding for Dr Reddy’s Risperidone (1 page, 34 KB)
30 September 2009 Approval of funding for Dr Reddy’s Risperidone PHARMAC is pleased to announce the approval of an agreement with Dr Reddy’s New Zealand Ltd to fund a new brand of risperidone tablets (Dr Reddy’s Risperidone). Details of the…
Information relating to the third pharmacy payment (3 pages, 122 KB)
Information relating to the 3rd pharmacy payment What if I have not received my payment? Cheques were posted on Wednesday 30 September. If you have not received your cheque within 5 working days you can call PHARMAC’s help line on…
Notification of approval of funding for mirtazapine (2 pages, 38 KB)
30 September 2009 Funding for mirtazapine (Avanza) approved PHARMAC is pleased to announce the approval of an agreement with Schering-Plough to fund the antidepressant mirtazapine (Avanza), subject to Special Authority restrictions, from 1 November 2009. Details of the decision Mirtazapine…
September Tender Results (4 pages, 123 KB)
30 September 2009 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept and decline tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender…
Notification - lansoprazole (Solox) supply agreement approved (1 page, 22 KB)
28 September 2009 Lansoprazole (Solox) supply agreement approved PHARMAC is pleased to announce the approval of a supply agreement with Douglas Pharmaceuticals for lansoprazole (Solox). Lansoprazole is a proton-pump inhibitor used in the management of various conditions including reflux oesophagitis,…
Approval of Multiple Diabetes Management Products (3 pages, 195 KB)
9 September 2009 Approval of Multiple Diabetes Management Products PHARMAC is pleased to announce the approval of 3 agreements in relation to funding of blood glucose diagnostic test meters and blood glucose diagnostic test strips (with and without lancets). These…
Notification of approved proposal relating to alendronate, aprepitant, raltegravir, levodopa with carbidopa, timolol and dorzolamide with timolol (5 pages, 87 KB)
3 September 2009 Approval of proposal for alendronate, aprepitant, raltegravir, levodopa with carbidopa, timolol and dorzolamide with timolol PHARMAC is pleased to announce the approval of an agreement with Merck Sharp & Dohme (New Zealand) Limited (MSD) for the above…
